FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Industries

  • Medicine ‎1
    • Tissue Engineering ‎1

Contact Info

Location

Affibody Medical AB

  • 1Product
  • 1Types
  • 1Industry

About Company

Affibody is a clinical stage Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. The company operates a focused experimental medicines model and currently has four clinical or late stage preclinical proprietary programs. The first three are therapeutic programs that targets psoriasis, B-cell driven autoimmune diseases, and liver diseases

Affibody is a clinical stage Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. The company operates a focused experimental medicines model and currently has four clinical or late stage preclinical proprietary programs. The first three are therapeutic programs that targets psoriasis, B-cell driven autoimmune diseases, and liver diseases respectively. The fourth program is a diagnostic imaging program that is directed primarily towards metastatic breast cancer. In addition, to its portfolio of innovative drug projects the company offers the half-life extension technology, Albumod™, for outlicensing. Affibody has ongoing commercial relationships with several companies such as AbClon, Biotest, Daewoong, Daiichi Sankyo, GE Healthcare, and Swedish Orphan Biovitrum.

Products

Anti-EGFR imaging agent

MEDICINE - TISSUE ENGINEERING   |  ANTIBODY

Anti-EGFR imaging agent

Properties :

Good tissue penetration,Biodistribution flexibility,Sub cutaneous formulation

Analytical Reports